297 related articles for article (PubMed ID: 2338544)
1. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
[TBL] [Abstract][Full Text] [Related]
2. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
[TBL] [Abstract][Full Text] [Related]
5. Subchronic methamphetamine treatment enhances ouabain-induced striatal dopamine efflux in vivo.
Kanzaki A; Akiyama K; Otsuki S
Brain Res; 1992 Jan; 569(2):181-8. PubMed ID: 1371707
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis.
Butcher SP; Liptrot J; Aburthnott GW
Neurosci Lett; 1991 Jan; 122(2):245-8. PubMed ID: 1902922
[TBL] [Abstract][Full Text] [Related]
7. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
Santiago M; Westerink BH
J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine releases dopamine in rat corpus striatum: an in vivo microdialysis study.
Harsing LG; Sershen H; Toth E; Hashim A; Ramacci MT; Lajtha A
Eur J Pharmacol; 1992 Jul; 218(1):117-21. PubMed ID: 1397026
[TBL] [Abstract][Full Text] [Related]
9. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
Robertson GS; Damsma G; Fibiger HC
J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
[TBL] [Abstract][Full Text] [Related]
10. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
Taglialatela M; Amoroso S; Kaparos G; Maurano F; Di Renzo GF; Annunziato L
J Pharmacol Exp Ther; 1988 Aug; 246(2):682-8. PubMed ID: 2457079
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying domoic acid-induced dopamine release from striatum: an in vivo microdialysis study.
Alfonso M; Durán R; Campos F; Perez-Vences D; Faro LR; Arias B
Neurochem Res; 2003 Oct; 28(10):1487-93. PubMed ID: 14570393
[TBL] [Abstract][Full Text] [Related]
12. Endogenous dopamine release from rat striatal slices and its regulation by D-2 autoreceptors: effects of uptake inhibitors and synthesis inhibition.
Herdon H; Strupish J; Nahorski SR
Eur J Pharmacol; 1987 Jun; 138(1):69-76. PubMed ID: 3622608
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter.
Faro LR; do Nascimento JL; Alfonso M; Durán R
Neurochem Int; 2002 Apr; 40(5):455-65. PubMed ID: 11821154
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects and mechanisms of action of flutriafol, a triazole fungicide, on striatal dopamine release by using in vivo microdialysis in freely moving rats.
Santana MB; Rodrigues KJ; Durán R; Alfonso M; Vidal L; Campos F; De Oliveira IM; Faro LR
Ecotoxicol Environ Saf; 2009 Jul; 72(5):1565-71. PubMed ID: 19232726
[TBL] [Abstract][Full Text] [Related]
15. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U
J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat.
Santiago M; Westerink BH
Neurochem Int; 1992 Mar; 20 Suppl():107S-110S. PubMed ID: 1365406
[TBL] [Abstract][Full Text] [Related]
17. Halothane enhances dopamine metabolism at presynaptic sites in a calcium-independent manner in rat striatum.
Adachi YU; Satomoto M; Higuchi H; Watanabe K; Yamada S; Kazama T
Br J Anaesth; 2005 Oct; 95(4):485-94. PubMed ID: 16113039
[TBL] [Abstract][Full Text] [Related]
18. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
19. Direct observation of dopamine compartmentation in striatal nerve terminal by 'in vivo' measurement of the specific activity of released dopamine.
Leviel V; Gobert A; Guibert B
Brain Res; 1989 Oct; 499(2):205-13. PubMed ID: 2804675
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
